- Home
- FSM vs LIVN Comparison
FSM vs LIVN Comparison
Compare FSM & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSM
- LIVN
- Stock Information
- Founded
- FSM 1990
- LIVN 1987
- Country
- FSM Canada
- LIVN United Kingdom
- Employees
- FSM N/A
- LIVN N/A
- Industry
- FSM Precious Metals
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FSM Basic Materials
- LIVN Health Care
- Exchange
- FSM Nasdaq
- LIVN Nasdaq
- Market Cap
- FSM 1.9B
- LIVN 2.2B
- IPO Year
- FSM N/A
- LIVN 1993
- Fundamental
- Price
- FSM $6.37
- LIVN $35.58
- Analyst Decision
- FSM Hold
- LIVN Buy
- Analyst Count
- FSM 1
- LIVN 7
- Target Price
- FSM $7.00
- LIVN $60.29
- AVG Volume (30 Days)
- FSM 15.4M
- LIVN 772.6K
- Earning Date
- FSM 05-06-2025
- LIVN 05-07-2025
- Dividend Yield
- FSM N/A
- LIVN N/A
- EPS Growth
- FSM N/A
- LIVN 262.50
- EPS
- FSM N/A
- LIVN 1.16
- Revenue
- FSM $1,062,037,000.00
- LIVN $1,253,437,000.00
- Revenue This Year
- FSM N/A
- LIVN $5.79
- Revenue Next Year
- FSM N/A
- LIVN $5.35
- P/E Ratio
- FSM $15.17
- LIVN $30.67
- Revenue Growth
- FSM 26.07
- LIVN 8.66
- 52 Week Low
- FSM $3.86
- LIVN $32.48
- 52 Week High
- FSM $6.76
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- FSM 60.30
- LIVN 40.50
- Support Level
- FSM $6.28
- LIVN $32.65
- Resistance Level
- FSM $6.61
- LIVN $35.89
- Average True Range (ATR)
- FSM 0.43
- LIVN 1.91
- MACD
- FSM 0.03
- LIVN 0.05
- Stochastic Oscillator
- FSM 76.07
- LIVN 42.70
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.